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The NHS outcomes framework 2012-3
The framework continues to develop but its implementation will pose many challenges
David A Cromwell senior lecturer, Nicholas Mays professor of health policy
Department of Health Services Research and Policy, London School of Tropical Medicine and Hygiene, London WC1E 7HT, UK
The NHS outcomes framework forms a central part of the
English NHS reforms. It is planned to be part of the system of
accountability between the secretary of state for health and the
new NHS Commissioning Board, and it is designed to ensure
that local clinical commissioning groups focus on the outcomes
achieved for patients rather than the process used to achieve
them.1 Clinical commissioning groups will be able to contract
with any qualified healthcare provider, a freedom that is
expected to deliver innovation and increase productivity,2 but
the care delivered to patients should also be consistent with a
high quality evidence based service described in the quality
standards.3
The Commissioning Board will be expected to achieve
improvements on the indicators in the framework.1 The required
level of improvement will reflect the cost effectiveness of
potential actions and inequalities in outcomes between
disadvantaged groups and areas. To reduce the risk of the
Commissioning Board focusing on a narrow set of priorities,
the framework covers a broad array of NHS activity. This has
stimulated a substantial amount of work aimed at producing a
robust set of outcome indicators, and refinements to the
framework are expected to be ongoing.
In the 2012-3 framework, the number of indicators has increased
from 51 to 60, some indicator definitions have been altered, and
the method of calculating 36 indicators has been finalised. Four
indicators are still to be developed and 20 others are to be
finalised.
Many changes are welcome, such as new indicators that extend
the framework to cover services for patients with dementia and
for people with learning difficulties. Other changes have made
indicators more specific. For example, the 2011-2 indicator on
patient reported outcomes after elective surgery combined
information about four procedures (surgery for groin hernias,
hip replacement, knee replacement, and varicose vein surgery),
but it would have been difficult to interpret this composite
indicator because the treatment effect for each procedure is
different.4 This indicator has now been replaced by separate
indicators for the four procedures.
The new commitment to align the NHS outcomes framework
with the public health outcomes framework and the adult social
care outcomes framework is another welcome development.
The importance of clinical and public health services to
population health was recently illustrated by a study that
estimated that half the decline in deaths from coronary heart
disease in the United States between 1980 and 2000 was due to
the reduced prevalence of major risk factors and half to
improved treatment.5 Indicators on avoidable mortality will be
shared with the public health outcomes framework, whereas
indicators that will be shared with the adult social care outcomes
framework will cover older people who require rehabilitation,
people with long term conditions, people with mental illness,
and carers. This is aimed at promoting greater cooperation
between services. However, it is unclear whether the incentives
for cooperation will outweigh other pressures, such as budget
constraints. This is particularly uncertain for NHS and public
health services because of the planned fragmentation of public
health responsibilities between the Department of Health and
local government.6
The construction of specific indicators also raises questions.
Several indicators use the EuroQol (EQ-5D) scale—a generic
measure of health status—as the outcome metric, even though
better alternatives are available. For elective hip replacement,
the Oxford hip score has been recommended ahead of the EQ-5D
for the assessment of outcomes,7 and data from this disease
specific measure are collected nationally.
For other indicators, such as that on neonatal death, it is not
clear whether variations in outcomes will predominantly reflect
the quality of care and whether cost effective actions that
produce better outcomes are available to the NHS. No onewould
dispute that it is profoundly important to measure and reduce
the rate of neonatal death. However, for a substantial proportion
of deaths, there is no obvious maternal risk factor, and research
into better prevention remains a priority.8
The example of the neonatal mortality indicator also highlights
the challenge that the Commissioning Board will face in
translating the framework into a system for holding clinical
commissioning groups to account. Although a fourfold
difference was seen between primary care trusts in the 2008
rates of neonatal mortality, the Centre for Maternal and Child
Enquiries (CMACE) concluded that much of this was the result
of random variation.9 To inspire public confidence, any system
of accountability needs to be built around indicators that can
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detect systematic differences between organisations. It would
be useful if the technical documentation on the framework
included information for each indicator on how much of the
variation observed between organisations arises from
unexplained differences as opposed to random variation.
The NHS outcomes framework represents an evolution in the
production of performance information on NHS services. It
extends the definition of quality contained inHigh Quality Care
for All,10 and many of its priority areas (as well as some
indicators) are recognisable from the 2005-8 public service
agreements.11 In 2012, work will continue on the technical
challenges of defining indicators, and a public consultation is
planned on the levels of improvement the board should aim to
achieve.1 An improvement to the quality and range of
information about healthcare outcomes is a positive
development. It will increase transparency and, in general, aid
accountability. However, accountability is also determined by
the culture and behaviour of organisations and the power
relationships between them.12 Exactly how relationships and
organisational cultures will develop in the new commissioning
regime remains to be seen, and it not yet clear that the newNHS
outcomes framework will prove to be fit for purpose.
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